\-\ Texto\\:\\ \ \(0\)\
\-\ following\\ dose\\ of\\ 12\\.0\\ mci\\ f\\-18\\ fdg\\,\\ standard\\ whole\\ body\\ positron\\ emission\\ tomography\\ was\\ performed\\,\\ including\\ a\\ \\"non\\-dedicated\\"\\ image\\ of\\ the\\ brain\\.\\ selected\\ coronal\\ and\\ axial\\ pet\\ images\\ of\\ the\\ brain\\ demonstrate\\ markedly\\ decreased\\ right\\ cerebral\\ metabolism\\ most\\ marked\\ in\\ the\\ right\\ parietal\\ lobe\\,\\ as\\ well\\ as\\ decreased\\ contralateral\\ cerebellar\\ activity\\.\ \(0\)\
\-\ crossed\\ cerebellar\\ diaschisis\\ \\(most\\ likely\\ based\\ upon\\ scintigraphic\\ appearance\\ and\\ history\\)\ \(0\)\
\-\ multifocal\\ infarct\ \(0\)\
\-\ developmental\\ anomoly\ \(0\)\
\-\ crossed\\ cerebellar\\ diaschisis\ \(0\)\
\-\ 70\\ year\\ old\\ male\\ with\\ history\\ of\\ abdominal\\ liposarcoma\\ referred\\ for\\ evaluation\\ for\\ metastatic\\ disease\\.\\ \\ additional\\ history\\ included\\ stroke\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ diaschisis\\:\\ 0\\.3715135657382111\ \(0\)\
\-\ cerebellar\\:\\ 0\\.2984303953791377\ \(0\)\
\-\ crossed\\:\\ 0\\.2951502773604909\ \(0\)\
\-\ anomoly\\:\\ 0\\.19439707457938374\ \(0\)\
\-\ positron\\:\\ 0\\.16485572210080185\ \(0\)\
\-\ emission\\:\\ 0\\.15450975379899956\ \(0\)\
\-\ brain\\:\\ 0\\.15155738064873267\ \(0\)\
\-\ decreased\\:\\ 0\\.15059055288836004\ \(0\)\
\-\ history\\:\\ 0\\.1393261272327578\ \(0\)\
\-\ mci\\:\\ 0\\.13893484696996725\ \(0\)\
\-\ metabolism\\:\\ 0\\.13893484696996725\ \(0\)\
\-\ scintigraphic\\:\\ 0\\.13815986769760005\ \(0\)\
\-\ fdg\\:\\ 0\\.13165231259033228\ \(0\)\
\-\ selected\\:\\ 0\\.13055927396030698\ \(0\)\
\-\ liposarcoma\\:\\ 0\\.13003308472329678\ \(0\)\
\-\ whole\\:\\ 0\\.12758100547809192\ \(0\)\
\-\ most\\:\\ 0\\.12652451782305799\ \(0\)\
\-\ contralateral\\:\\ 0\\.1215667497452589\ \(0\)\
\-\ multifocal\\:\\ 0\\.11803378620166355\ \(0\)\
\-\ tomography\\:\\ 0\\.11773985628144602\ \(0\)\
\-\ dose\\:\\ 0\\.11351678889791725\ \(0\)\
\-\ stroke\\:\\ 0\\.11304322315650679\ \(0\)\
\-\ standard\\:\\ 0\\.11281032923880098\ \(0\)\
\-\ pet\\:\\ 0\\.11257995314249122\ \(0\)\
\-\ markedly\\:\\ 0\\.10732662990794087\ \(0\)\
\-\ developmental\\:\\ 0\\.10511728597966587\ \(0\)\
\-\ included\\:\\ 0\\.10511728597966587\ \(0\)\
\-\ infarct\\:\\ 0\\.10115152431034026\ \(0\)\
\-\ 70\\:\\ 0\\.10036219031775293\ \(0\)\
\-\ parietal\\:\\ 0\\.09815578179568973\ \(0\)\
\-\ as\\:\\ 0\\.09766800861884425\ \(0\)\
\-\ coronal\\:\\ 0\\.09680233770893552\ \(0\)\
\-\ upon\\:\\ 0\\.09563294011851214\ \(0\)\
\-\ of\\:\\ 0\\.09515314153339965\ \(0\)\
\-\ additional\\:\\ 0\\.09423180578874016\ \(0\)\
\-\ marked\\:\\ 0\\.09193824139319431\ \(0\)\
\-\ referred\\:\\ 0\\.08994679348372836\ \(0\)\
\-\ activity\\:\\ 0\\.08924550082759418\ \(0\)\
\-\ based\\:\\ 0\\.08805304534482908\ \(0\)\
\-\ including\\:\\ 0\\.08699264840823395\ \(0\)\
\-\ cerebral\\:\\ 0\\.08421622521136217\ \(0\)\
\-\ right\\:\\ 0\\.08060275163182322\ \(0\)\
\-\ body\\:\\ 0\\.08000064143857263\ \(0\)\
\-\ image\\:\\ 0\\.07774055636077112\ \(0\)\
\-\ evaluation\\:\\ 0\\.0741326473303218\ \(0\)\
\-\ for\\:\\ 0\\.07368635470497954\ \(0\)\
\-\ appearance\\:\\ 0\\.07328236910553812\ \(0\)\
\-\ following\\:\\ 0\\.07292300845841679\ \(0\)\
\-\ the\\:\\ 0\\.07276544077192615\ \(0\)\
\-\ likely\\:\\ 0\\.07263982048535848\ \(0\)\
\-\ performed\\:\\ 0\\.07191387646919631\ \(0\)\
\-\ lobe\\:\\ 0\\.07024745128195656\ \(0\)\
\-\ axial\\:\\ 0\\.07021604437669732\ \(0\)\
\-\ metastatic\\:\\ 0\\.06666826586948972\ \(0\)\
\-\ abdominal\\:\\ 0\\.06648307901871102\ \(0\)\
\-\ demonstrate\\:\\ 0\\.06319442994807185\ \(0\)\
\-\ well\\:\\ 0\\.05885879187824211\ \(0\)\
\-\ images\\:\\ 0\\.0562284854970831\ \(0\)\
\-\ male\\:\\ 0\\.054122122141697676\ \(0\)\
\-\ disease\\:\\ 0\\.051025564478635106\ \(0\)\
\-\ and\\:\\ 0\\.050236781960642185\ \(0\)\
\-\ was\\:\\ 0\\.04236402904078653\ \(0\)\
\-\ year\\:\\ 0\\.03746166079218245\ \(0\)\
\-\ old\\:\\ 0\\.03597616203619167\ \(0\)\
\-\ in\\:\\ 0\\.03023958723771503\ \(0\)\
\-\ with\\:\\ 0\\.02380249887819803\ \(0\)\
